Objective Daytime Napping is Associated with Disease Severity and Inflammation in Patients with Mild to Moderate Dementia1.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2020
Historique:
pubmed: 3 3 2020
medline: 20 4 2021
entrez: 3 3 2020
Statut: ppublish

Résumé

Patients with dementia report excessive daytime sleep/sleepiness, which is associated with worse cognitive performance. Inflammatory markers may be elevated in patients with dementia and have been proposed as mediators of sleep/sleepiness. To examine the association of objective daytime napping with cognitive performance and peripheral markers of inflammation in patients with dementia as compared to not cognitively impaired (NCI) controls. A sub-sample of 46 patients with mild-to-moderate dementia and 85 NCI controls, were recruited from a large, population-based cohort of 3,140 elders (≥60 years) in Crete, Greece. All participants underwent medical history/physical examination, extensive neuropsychiatric and neuropsychological evaluation, 3-day 24 h actigraphy and a single morning measure of IL-6 and TNFα plasma levels. Comparisons of sleep parameters and inflammation markers between diagnostic groups, and between nappers and non-nappers within each diagnostic group, were conducted using ANCOVA controlling for demographics/related clinical factors. Associations between inflammatory markers, sleep variables, and neuropsychological performance were assessed within each group using partial correlation analysis controlling for confounders. Patients with dementia slept 15 minutes longer during the day than NCI. Within dementia patients, nappers had significantly worse performance on autobiographic memory (p = 0.002), working memory (p = 0.007), episodic memory (p = 0.010), and assessment of daily function (p = 0.012) than non-nappers. Finally, IL-6 levels were significantly associated with nap duration within dementia patients who napped (r = 0.500, p = 0.01). Daytime napping in patients with dementia is associated with worse cognitive performance and increased IL-6 levels. In dementia, objective daytime napping, may be a marker of the severity of the disease.

Sections du résumé

BACKGROUND
Patients with dementia report excessive daytime sleep/sleepiness, which is associated with worse cognitive performance. Inflammatory markers may be elevated in patients with dementia and have been proposed as mediators of sleep/sleepiness.
OBJECTIVE
To examine the association of objective daytime napping with cognitive performance and peripheral markers of inflammation in patients with dementia as compared to not cognitively impaired (NCI) controls.
METHODS
A sub-sample of 46 patients with mild-to-moderate dementia and 85 NCI controls, were recruited from a large, population-based cohort of 3,140 elders (≥60 years) in Crete, Greece. All participants underwent medical history/physical examination, extensive neuropsychiatric and neuropsychological evaluation, 3-day 24 h actigraphy and a single morning measure of IL-6 and TNFα plasma levels. Comparisons of sleep parameters and inflammation markers between diagnostic groups, and between nappers and non-nappers within each diagnostic group, were conducted using ANCOVA controlling for demographics/related clinical factors. Associations between inflammatory markers, sleep variables, and neuropsychological performance were assessed within each group using partial correlation analysis controlling for confounders.
RESULTS
Patients with dementia slept 15 minutes longer during the day than NCI. Within dementia patients, nappers had significantly worse performance on autobiographic memory (p = 0.002), working memory (p = 0.007), episodic memory (p = 0.010), and assessment of daily function (p = 0.012) than non-nappers. Finally, IL-6 levels were significantly associated with nap duration within dementia patients who napped (r = 0.500, p = 0.01).
CONCLUSIONS
Daytime napping in patients with dementia is associated with worse cognitive performance and increased IL-6 levels. In dementia, objective daytime napping, may be a marker of the severity of the disease.

Identifiants

pubmed: 32116246
pii: JAD190483
doi: 10.3233/JAD-190483
doi:

Substances chimiques

IL6 protein, human 0
Interleukin-6 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

803-815

Auteurs

Maria Basta (M)

Department of Psychiatry, University Hospital of Heraklion, Heraklion, Crete, Greece.
Sleep Research and Treatment Center, Department of Psychiatry, Penn State University, Hershey, PA, USA.

Eirini Koutentaki (E)

Department of Psychiatry, University Hospital of Heraklion, Heraklion, Crete, Greece.

Alexandros Vgontzas (A)

Department of Psychiatry, University Hospital of Heraklion, Heraklion, Crete, Greece.
Sleep Research and Treatment Center, Department of Psychiatry, Penn State University, Hershey, PA, USA.

Ioannis Zaganas (I)

Department of Neurology, University Hospital of Heraklion, Heraklion, Crete, Greece.

Emmanouela Vogiatzi (E)

Department of Neurology, University Hospital of Heraklion, Heraklion, Crete, Greece.

Garyfalia Gouna (G)

Department of Neurology, University Hospital of Heraklion, Heraklion, Crete, Greece.

Mara Bourbouli (M)

Department of Neurology, University Hospital of Heraklion, Heraklion, Crete, Greece.

Symeon Panagiotakis (S)

Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Crete, Greece.

Stefania Kapetanaki (S)

Department of Neurology, University Hospital of Heraklion, Heraklion, Crete, Greece.

Julio Fernandez-Mendoza (J)

Sleep Research and Treatment Center, Department of Psychiatry, Penn State University, Hershey, PA, USA.

Panagiotis Simos (P)

Department of Psychiatry, University Hospital of Heraklion, Heraklion, Crete, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH